Dr.Reddys Laboratories | DRRD - Sales Revenues

Stock Price
1,333.00
Daily Change
-3.70 -0.28%
Monthly
8.15%
Yearly
9.35%
Q2 Forecast
1,308.09

Dr.Reddys Laboratories reported INR75.46B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Bharat Petroleum INR 1.24T 150B Mar/2026
Cipla INR 65.41B 9.77B Mar/2026
Dr.Reddys Laboratories INR 75.46B 11.81B Mar/2026
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 183.35B 59.74B Mar/2026